|
13 Sep 2025 |
Jyothy Labs
|
Consensus Share Price Target
|
325.20 |
399.38 |
- |
22.81 |
buy
|
|
|
|
|
21 Oct 2015
|
Jyothy Labs
|
Reliance Securities
|
325.20
|
283.00
|
311.60
(4.36%)
|
Pre-Bonus/ Split |
Hold
|
|
|
Jyothy Laboratories (JYL) posted 9% growth in consolidated revenues to Rs4bn in 2QFY16, slightly ahead of our estimate of Rs3.9bn. Both EBITDA and net profit were ahead of our expectation as they grew 46% to Rs485mn and by 54% to Rs388mn, respectively. Absolute fall in A&P; spends aided EBITDA and net profit to perform better. Volume growth stood at 9%. On an expected EPS of Rs10.1 for FY17E, the stock is...
|
|
13 Jul 2015
|
Jyothy Labs
|
Way2Wealth
|
325.20
|
|
305.45
(6.47%)
|
Pre-Bonus/ Split |
Accumulate
|
|
|
Way2Wealth Brokers Pvt. Ltd. (CIN U67120KA2000PTC027628) SEBI Rgn. No. : Applied for. No. 14, Frontline Granduer, Walton Road, Bangalore-560001; Website: www.way2wealth.com Email: research@way2wealth.com...
|
|
02 Jul 2012
|
Jyothy Labs
|
Ajcon Global
|
325.20
|
|
115.50
(181.56%)
|
Pre-Bonus/ Split |
Accumulate
|
|
|
|